Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Imdevimab Emergency use authorization Experimental Antiviral Jan/23/2023 31 11
Casirivimab Emergency use authorization Experimental Antiviral Jan/23/2023 26 16
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 73 5
Regdanvimab Authorized Experimental Antiviral Jan/18/2023 6 4
Sotrovimab Emergency use authorization Experimental Antiviral Jul/14/2022 7 2
Etesevimab Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022 5 16
Nirmatrelvir Emergency use authorization Experimental Antiviral Jun/23/2022 7 0
Bamlanivimab Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022 11 15
Molnupiravir Emergency use authorization Experimental Antiviral Jun/23/2022 17 1
Ad26.COV2.S Emergency use authorization Experimental Vaccine Jun/22/2022 10 1